Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways

• Asıl Yazarlar: Kenji Ichikawa (Yazar), Saori Watanabe Miyano (Yazar), Yusuke Adachi (Yazar), Masahiro Matsuki (Yazar), Kiyoshi Okamoto (Yazar), Junji Matsui (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Global Journal of Cancer Therapy - Peertechz Publications, 2016-07-02.
• Konular: Research Article
• Online Erişim: Connect to this object online.

<p>Lenvatinib mesilate (lenvatinib) is an oral multiple-receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of Vascular Endothelial Growth Factor Receptor (VEGFR) 1-3, Fibroblast Growth Factor Receptor (FGFR) 1-4, Platelet-Derived Growth Factor Receptor (PDGFR) α...